Literature DB >> 20943913

Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway.

Bhupinder P S Vohra1, Yo Sasaki, Bradley R Miller, Jufang Chang, Aaron DiAntonio, Jeffrey Milbrandt.   

Abstract

Axonal degeneration is a hallmark of many debilitating neurological disorders and is thought to be regulated by mechanisms distinct from those governing cell body death. Recently, caspase 6 activation via amyloid precursor protein (APP) cleavage and activation of DR6 was discovered to induce axon degeneration after NGF withdrawal. We tested whether this pathway is involved in axonal degeneration caused by withdrawal of other trophic support, axotomy or vincristine exposure. Neurturin deprivation, like NGF withdrawal activated this APP/DR6/caspase 6 pathway and resulted in axonal degeneration, however, APP cleavage and caspase 6 activation were not involved in axonal degeneration induced by mechanical or toxic insults. However, loss of surface APP (sAPP) and caspase 6 activation were observed during axonal degeneration induced by dynactin 1(Dctn1) dysfunction, which disrupts axonal transport. Mutations in Dctn1 are associated with motor neuron disease and frontal temporal dementia, thus suggesting that the APP/caspase 6 pathway could be important in specific types of disease-associated axonal degeneration. The NGF deprivation paradigm, with its defined molecular pathway, was used to examine the context of Nmnat-mediated axonal protection. We found that although Nmnat blocks axonal degeneration after trophic factor withdrawal, it did not prevent loss of axon sAPP or caspase 6 activation within the axon, suggesting it acts downstream of caspase 6. These results indicate that diverse insults induce axonal degeneration via multiple pathways and that these degeneration signals converge on a common, Nmnat-sensitive program that is uniquely involved in axonal, but not cell body, degeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943913      PMCID: PMC3104322          DOI: 10.1523/JNEUROSCI.2939-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases.

Authors:  J T Finn; M Weil; F Archer; R Siman; A Srinivasan; M C Raff
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 2.  Trk receptors: roles in neuronal signal transduction.

Authors:  Eric J Huang; Louis F Reichardt
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

3.  Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis.

Authors:  G V Putcha; K L Moulder; J P Golden; P Bouillet; J A Adams; A Strasser; E M Johnson
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

4.  Mutant dynactin in motor neuron disease.

Authors:  Imke Puls; Catherine Jonnakuty; Bernadette H LaMonte; Erika L F Holzbaur; Mariko Tokito; Eric Mann; Mary Kay Floeter; Kimberly Bidus; Dennis Drayna; Shin J Oh; Robert H Brown; Christy L Ludlow; Kenneth H Fischbeck
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

Review 5.  Trks: signal transduction and intracellular pathways.

Authors:  L J Klesse; L F Parada
Journal:  Microsc Res Tech       Date:  1999 May 15-Jun 1       Impact factor: 2.769

Review 6.  The GDNF family: signalling, biological functions and therapeutic value.

Authors:  Matti S Airaksinen; Mart Saarma
Journal:  Nat Rev Neurosci       Date:  2002-05       Impact factor: 34.870

Review 7.  The GDNF family ligands and receptors - implications for neural development.

Authors:  R H Baloh; H Enomoto; E M Johnson; J Milbrandt
Journal:  Curr Opin Neurobiol       Date:  2000-02       Impact factor: 6.627

8.  Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.

Authors:  T G Mack; M Reiner; B Beirowski; W Mi; M Emanuelli; D Wagner; D Thomson; T Gillingwater; F Court; L Conforti; F S Fernando; A Tarlton; C Andressen; K Addicks; G Magni; R R Ribchester; V H Perry; M P Coleman
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

9.  Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration.

Authors:  Bernadette H LaMonte; Karen E Wallace; Beth A Holloway; Spencer S Shelly; Jennifer Ascaño; Mariko Tokito; Thomas Van Winkle; David S Howland; Erika L F Holzbaur
Journal:  Neuron       Date:  2002-05-30       Impact factor: 17.173

10.  Dynactin is required for bidirectional organelle transport.

Authors:  Sean W Deacon; Anna S Serpinskaya; Patricia S Vaughan; Monica Lopez Fanarraga; Isabelle Vernos; Kevin T Vaughan; Vladimir I Gelfand
Journal:  J Cell Biol       Date:  2003-01-27       Impact factor: 10.539

View more
  53 in total

Review 1.  Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.

Authors:  Josiah Gerdts; Daniel W Summers; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Neuron       Date:  2016-02-03       Impact factor: 17.173

2.  Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system.

Authors:  Mohamed H Farah; Bao Han Pan; Paul N Hoffman; Dana Ferraris; Takashi Tsukamoto; Thien Nguyen; Philip C Wong; Donald L Price; Barbara S Slusher; John W Griffin
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

3.  Image-based screening identifies novel roles for IkappaB kinase and glycogen synthase kinase 3 in axonal degeneration.

Authors:  Josiah Gerdts; Yo Sasaki; Bhupinder Vohra; Jayne Marasa; Jeffrey Milbrandt
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

4.  Nicotinamide Mononucleotide Adenylyltransferase 1 Protects Neural Cells Against Ischemic Injury in Primary Cultured Neuronal Cells and Mouse Brain with Ischemic Stroke Through AMP-Activated Protein Kinase Activation.

Authors:  Jia Liang; Peng Wang; Jia Wei; Cuifen Bao; Donghe Han
Journal:  Neurochem Res       Date:  2015-04-05       Impact factor: 3.996

Review 5.  Diverse cellular and molecular modes of axon degeneration.

Authors:  Lukas J Neukomm; Marc R Freeman
Journal:  Trends Cell Biol       Date:  2014-04-27       Impact factor: 20.808

6.  Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling.

Authors:  Vasanthy Vigneswara; Nsikan Akpan; Martin Berry; Ann Logan; Carol M Troy; Zubair Ahmed
Journal:  Brain       Date:  2014-04-10       Impact factor: 13.501

7.  Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death.

Authors:  Philip B Verghese; Yo Sasaki; Donghan Yang; Floy Stewart; Fatima Sabar; Mary Beth Finn; Christine M Wroge; Steven Mennerick; Jeffrey J Neil; Jeffrey Milbrandt; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-04       Impact factor: 11.205

8.  A caspase cascade regulating developmental axon degeneration.

Authors:  David J Simon; Robby M Weimer; Todd McLaughlin; Dara Kallop; Karen Stanger; Jing Yang; Dennis D M O'Leary; Rami N Hannoush; Marc Tessier-Lavigne
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

9.  Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of β-secretase.

Authors:  Olav Olsen; Dara Y Kallop; Todd McLaughlin; Sarah Huntwork-Rodriguez; Zhuhao Wu; Cynthia D Duggan; David J Simon; Yanmei Lu; Courtney Easley-Neal; Kentaro Takeda; Philip E Hass; Alexander Jaworski; Dennis D M O'Leary; Robby M Weimer; Marc Tessier-Lavigne
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

Review 10.  Axon degeneration: context defines distinct pathways.

Authors:  Matthew J Geden; Mohanish Deshmukh
Journal:  Curr Opin Neurobiol       Date:  2016-05-16       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.